Navigation Links
Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.

ALLENTOWN, Pa. and CAMPBELL, Calif., May 25 /PRNewswire/ -- HunterHeart offers physicians and patients sophisticated risk characterization and personalized therapy guidelines for cardiovascular disease.  HNL will be performing a battery of advanced tests, offering an accompanying nutrition program, and wellness coaching.  Gerry Weiss, MD, Hunter's Medical Director stated:  "With appropriate risk characterization and treatment, cardiovascular disease can be prevented for many patients and MI and stroke events can be significantly reduced."

"HNL's reputation for quality, service and innovation is exceptional.  Hunter is delighted to be working with HNL to reduce cardiovascular disease in PA and NJ," stated Chris Riedel, Hunter's CEO.  HNL's President and CEO, David G. Beckwith Ph.D., stated that, "The HunterHeart program will assist our physicians in delivering comprehensive cardiovascular health advice to their patients, and establishes HNL as a center of excellence for preventive cardiology."

About Health Network Laboratories

Based in Allentown, Pennsylvania, Health Network Laboratories (HNL) is a multi-regional medical laboratory with technologically advanced facilities in Pennsylvania and New Jersey.  HNL serves the need of the public and health care communities performing almost 6 million clinical and pathology tests each year.  HNL is consistently rated highly by physicians and clients in all areas of laboratory performance and customer satisfaction.

HNL offers a full complement of clinical laboratory and anatomic pathology services, including highly specialized esoteric testing to hospitals, physicians, long-term and assisted living facilities, businesses and government agencies.  For more information, visit

About Hunter Labs, Inc.

Hunter Laboratories is the largest locally owned and operated clinical reference laboratory in northern California.  HunterHeart is one of Hunter's proprietary disease detection and management programs that are being rolled-out across the U.S.  Hunter's Incelldx mRNA test for cervical cancer detection is also being introduced across the U.S.  This test is the only accurate HPV method for women under 30, and has better specificity for predicting CIN2/CIN3 on biopsy.  For more information, visit

SOURCE Hunter Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
2. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
3. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
4. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
5. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
6. Home Health Monitoring May Significantly Improve Blood Pressure Control, Kaiser Permanente Study Finds
7. Accuray Incorporated to Present at Citi Global Health Care Conference
8. Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference
9. Inverness Medical Innovations to Attend the Citi Global Health Care Conference on May 26, 2010
10. Medco to Present at the 2010 Citi Investment Research Global Health Care Conference
11. WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals
Post Your Comments:
(Date:11/30/2015)... 30, 2015   Royal Philips (NYSE: ... industry,s first MRI guided user interface and automatic scan ... with MR Conditional implants, such as knee and hip ... Radiological Society of North America Annual Meeting (RSNA) . ... diagnostic confidence of this growing patient population. ScanWise Implant ...
(Date:11/30/2015)... India , November 30, 2015 ... 2014, and is expected to grow at a CAGR of 7.6% ... was valued at USD 135.6 million in 2014, and is ... 2020. --> According to the new Market Research Report ... invasive, non-invasive), By End User (Hospitals, ambulatory care, others) - Analysis ...
(Date:11/30/2015)... 2015 2014RestatedChange%Turnover 545,575 , 518,852 , 5.2 Cord Blood ... , 9.8 Hospital Management Service Income , ... Medical Insurance Administration Service Income , 2,780 , ... , 89,645 , 94,580 , ... 2,917 , (3.3) Gross Profit 395,857 , ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 2015 , ... Live Very Well is excited to announce ... . The multi-carrier insurance exchange platform offers individual vision and dental ... compare, quote and match plans to meet their needs. , Beginning December ...
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. ... in the MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was ... a BMI of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight ...
(Date:11/30/2015)... ... 30, 2015 , ... Stress, anxiety, illness, infection or even a need for ... , Heather Spader, MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in ... to tumors. , “Bad headaches that don’t go away, that don’t have ...
(Date:11/30/2015)... ... November 30, 2015 , ... Thermi™, a ... to announce that its ThermiRFR temperature controlled radiofrequency platform has received CE marking ... radiofrequency platform which uses temperature as a clinical endpoint. The technology has ...
(Date:11/30/2015)... ... 30, 2015 , ... MOSI recently added two state-of-the-art augmented reality (AR) experiences ... Jurassic to their collection of interactive exhibits within the Kids In Charge! building. In ... guests to get closer than ever to a range of animals as they drink, ...
Breaking Medicine News(10 mins):